Litigation Details for Pfizer Inc. v. Umedica Laboratories Pvt., Ltd. (D. Del. 2017)
✉ Email this page to a colleague
Pfizer Inc. v. Umedica Laboratories Pvt., Ltd. (D. Del. 2017)
| Docket | ⤷ Sign Up | Date Filed | 2017-10-31 |
| Court | District Court, D. Delaware | Date Terminated | 2018-05-31 |
| Cause | 35:271 Patent Infringement | Assigned To | Richard Gibson Andrews |
| Jury Demand | None | Referred To | |
| Patents | 6,469,012 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Pfizer Inc. v. Umedica Laboratories Pvt., Ltd.
The small molecule drug covered by the patent cited in this case is ⤷ Sign Up .
Details for Pfizer Inc. v. Umedica Laboratories Pvt., Ltd. (D. Del. 2017)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2017-10-31 | 1 | infringement of United States Patent No. 6,469,012 (the “’012 patent”). 2. This action…BACKGROUND The ’012 Patent 14. On October 22, 2002, the United States Patent and Trademark Office…proceedings, confirmed the patentability of claims 1–23, 25, and 26 of the ’012 patent over numerous prior … claim 24 not patentable. Pfizer is only asserting claims 25 and 26 of the ’012 patent in this case. …and 26 of the ’012 patent valid, enforceable, and infringed. A copy of the ’012 patent is attached hereto | External link to document | |
| 2018-05-31 | 17 | Patent/Trademark Report to Commissioner of Patents | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,469,012 B1. (Attachments: #… 2017 31 May 2018 1:17-cv-01551 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
| 2017-10-31 | 4 | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,469,012 B1;. (sar) (Entered… 2017 31 May 2018 1:17-cv-01551 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
